Results 231 to 240 of about 8,638,542 (419)

A large‐scale retrospective study in metastatic breast cancer patients using circulating tumour DNA and machine learning to predict treatment outcome and progression‐free survival

open access: yesMolecular Oncology, EarlyView.
There is an unmet need in metastatic breast cancer patients to monitor therapy response in real time. In this study, we show how a noninvasive and affordable strategy based on sequencing of plasma samples with longitudinal tracking of tumour fraction paired with a statistical model provides valuable information on treatment response in advance of the ...
Emma J. Beddowes   +20 more
wiley   +1 more source

Point-of-Care Testing

open access: yesBiomedical Instrumentation & Technology, 2009
Arika Mittal Suri   +2 more
openaire   +5 more sources

Prevalence of high-risk human papillomavirus genotypes in outpatient Malian women living with HIV: a pilot study

open access: yesBMC Infectious Diseases
Introduction Long-term exposure to high-risk human papillomavirus (Hr-HPV) is a well-known necessary condition for development of cervical cancer. The aim of this study is to screen for Hr-HPV using vaginal self-sampling, which is a more effective ...
Ban Traore   +23 more
doaj   +1 more source

Point-of-Care Measured Platelet Inhibition Correlates With a Reduced Risk of an Adverse Cardiac Event After Percutaneous Coronary Intervention [PDF]

open access: bronze, 2001
Steven R. Steinhubl   +18 more
openalex   +1 more source

Towards voltammetric point of care detection of leucovorin [PDF]

open access: yes
Current healthcare trends have seen an increased emphasis on the move towards personalised precision medicine to tailor treatments to the individual and their response to diseases and disease therapies.
Dennany, Lynn, Shum, Pui Hang
core  

ShcD adaptor protein drives invasion of triple negative breast cancer cells by aberrant activation of EGFR signaling

open access: yesMolecular Oncology, EarlyView.
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau   +11 more
wiley   +1 more source

Facing Unmet Needs in Medicine Access at the Point of Care

open access: yesMedicine Access @ Point of Care, 2017
Giulio Zuanetti
doaj   +1 more source

Perspectives On Blood-Based Point-Of-Care Diagnostics

open access: yesOpen Access Emergency Medicine, 2019
Karalee Quig,1 Elizabeth G Wheatley,2 Matthew O’Hara2 1POC Testing Consultant, Aurora, CO, USA; 2Boston Strategic Partners, Inc., Boston, MA, USACorrespondence: Matthew O’HaraBoston Strategic Partners, Inc., 4 Wellington Street Suite 3 ...
Quig K, Wheatley EG, O’Hara M
doaj  

Home - About - Disclaimer - Privacy